These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 456627)

  • 41. [Historical survey of modern reversible contraceptive methods].
    Mbabajende V
    Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postpartum contraception: subsequent pregnancy, delivery, and abortion rates.
    Shulman JJ; Merritt CG
    Fertil Steril; 1976 Jan; 27(1):97-103. PubMed ID: 1245250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):572-7. PubMed ID: 24679477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of the intrauterine device in nulliparous and parous women.
    Veldhuis HM; Vos AG; Lagro-Janssen AL
    Eur J Gen Pract; 2004 Sep; 10(3):82-7. PubMed ID: 15534571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contraception in Japan.
    Marsumoto S
    IPPF Med Bull; 1969; 3(4):2-3. PubMed ID: 12331996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved utilization of spacing methods--intrauterine devices (IUDs) and low-dose combined oral contraceptives (OCs)--through re-orientation training for improving quality of services. Indian Council of Medical Research Task Force on IUD and Hormonal Contraceptives.
    Contraception; 1994 Sep; 50(3):215-28. PubMed ID: 7805372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventing repeat abortion in Canada: is the immediate insertion of intrauterine devices postabortion a cost-effective option associated with fewer repeat abortions?
    Ames CM; Norman WV
    Contraception; 2012 Jan; 85(1):51-5. PubMed ID: 22067796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contraceptive knowledge, attitudes, and practice in Russia during the 1980s.
    Popov AA; Visser AP; Ketting E
    Stud Fam Plann; 1993; 24(4):227-35. PubMed ID: 8212092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of drugs and intrauterine devices for birth control.
    Meeker CI
    N Engl J Med; 1969 May; 280(19):1058-60. PubMed ID: 4180710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
    Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of acceptability, safety, and continuation rates of centchroman as postabortion nonsteroidal contraceptive pill.
    Agarwal K; Dewan R
    Contraception; 2023 May; 121():109961. PubMed ID: 36736648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The choice of a method of contraception during adolescence].
    Gaspard U
    Rev Med Liege; 1980 May; 35(9):377-90. PubMed ID: 7008134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The intrauterine device, pelvic inflammatory disease, and infertility: the confusion between hypothesis and knowledge.
    Grimes DA
    Fertil Steril; 1992 Oct; 58(4):670-3. PubMed ID: 1426307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Contraception and tubal sterility of infective origin].
    Gayer ML; Henry-Suchet J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):155-64. PubMed ID: 2324437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contraception after abortion.
    Margolis A; Rindfuss R; Coghlan P; Rochat R
    Fam Plann Perspect; 1974; 6(1):56-60. PubMed ID: 4459147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.